Clinical Trial Update: PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone [Phase 2]

View source ↗

Summary

Phase II non-comparative trial in metastatic castration-resistant prostate cancer evaluating a therapy in combination with prednisolone. The study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Prednisolone (Prednisolone)

Snippet

Sponsor: Sanofi | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED